AMGN has been in the news 346% more than usual
Jan 14, 2026, 1:31 AM
12.94%
What does AMGN do
Amgen, headquartered in Thousand Oaks, California, is a biotechnology company employing 26,700 staff, focusing on developing human therapeutics for high unmet medical needs. Its product portfolio includes Aranesp, ENBREL, and Prolia, among others.
AMGN has been in the news recently: Amgen is partnering with Ro to investigate barriers to care and enhance access to GLP-1 treatment for Americans facing obesity. Additionally, Amgen's CEO Bob Bradway revealed that their drug MariTide aids patients in sustaining weight loss for up to two years through monthly injections.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.